Nitric oxide donor trans-'[RuCl([15]ane'N IND.4')NO]'POT.2+'as a possible therapeutic approach for chagas' disease (2010)
- Authors:
- USP affiliated authors: FRANCO, DOUGLAS WAGNER - IQSC ; ZAMBONI, DARIO SIMÕES - FMRP ; SILVA, ROBERTO SANTANA DA - FCFRP ; SILVA, JOÃO SANTANA DA - FMRP
- Unidades: IQSC; FMRP; FCFRP
- DOI: 10.1111/j.1476-5381.2009.00576.x
- Subjects: DOENÇA DE CHAGAS (TRATAMENTO); QUÍMICA INORGÂNICA; QUÍMICA MÉDICA; TRYPANOSOMA CRUZI
- Language: Inglês
- Imprenta:
- Publisher place: Chichester
- Date published: 2010
- Source:
- Título: British Journal of Pharmacology
- ISSN: 0007-1188
- Volume/Número/Paginação/Ano: v. 160, n. 2, p. 270-282, 2010
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: bronze
-
ABNT
GUEDES, Paulo M M et al. Nitric oxide donor trans-'[RuCl([15]ane'N IND.4')NO]'POT.2+'as a possible therapeutic approach for chagas' disease. British Journal of Pharmacology, v. 160, n. 2, p. 270-282, 2010Tradução . . Disponível em: https://doi.org/10.1111/j.1476-5381.2009.00576.x. Acesso em: 17 jan. 2026. -
APA
Guedes, P. M. M., Oliveira, F. S., Gutierrez, F. R. S., Silva, G. K. da, Rodrigues, G. J., Bendhack, L. M., et al. (2010). Nitric oxide donor trans-'[RuCl([15]ane'N IND.4')NO]'POT.2+'as a possible therapeutic approach for chagas' disease. British Journal of Pharmacology, 160( 2), 270-282. doi:10.1111/j.1476-5381.2009.00576.x -
NLM
Guedes PMM, Oliveira FS, Gutierrez FRS, Silva GK da, Rodrigues GJ, Bendhack LM, Franco DW, Matta MADV, Zamboni DS, Silva RS da, Silva JS da. Nitric oxide donor trans-'[RuCl([15]ane'N IND.4')NO]'POT.2+'as a possible therapeutic approach for chagas' disease [Internet]. British Journal of Pharmacology. 2010 ; 160( 2): 270-282.[citado 2026 jan. 17 ] Available from: https://doi.org/10.1111/j.1476-5381.2009.00576.x -
Vancouver
Guedes PMM, Oliveira FS, Gutierrez FRS, Silva GK da, Rodrigues GJ, Bendhack LM, Franco DW, Matta MADV, Zamboni DS, Silva RS da, Silva JS da. Nitric oxide donor trans-'[RuCl([15]ane'N IND.4')NO]'POT.2+'as a possible therapeutic approach for chagas' disease [Internet]. British Journal of Pharmacology. 2010 ; 160( 2): 270-282.[citado 2026 jan. 17 ] Available from: https://doi.org/10.1111/j.1476-5381.2009.00576.x - Relevance of the myeloid differentiation factor 88 (MyD88) on RANKL, OPG, and nod expressions induced by TLR and IL-1R signaling in bone marrow stromal cells
- Resistance to Leishmania spp. is mediated by the inflammasome induced duo: IL- 1β and nitric oxide
- Role of NLRC4 inflammasome in Paracoccidioides brasiliensis pulmonary inflammation
- The inflammatose contributes for restriction of leishmania (Leishmania) amazonensis infection in macrophages and in vivo
- Restriction of Leishmania amazonensis infection by the inflammasomes
- Intrinsic expression of Nod2 in CD4+ T lymphocytes is not necessary for the development of cell-mediated immunity and host resistance to Toxoplasma gondii
- Cutting edge: nucleotide binding oligomerization domain 1-dependent responses account for murine resistance against trypanosoma cruzi infection
- Ros-dependent NLRP3-inflammasome activation is critical for restriction of Leishmania amazonensis infection
- The role of Rip2 in the signaling pathwy downstream of NOD1 in response to Trypanosoma cruz/infection
- Interplay between reactive oxygen species and the inflammasome are crucial for restriction of Neospora caninum replication
Informações sobre o DOI: 10.1111/j.1476-5381.2009.00576.x (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
